Cart
Orders
Not available here
Product Overview
Dermalax Plus, Dermalax Deep Plus and Dermalax Implant Plus are three cross-linked hyaluronic acid (HA) dermal fillers manufactured in South Korea by ACROSS Co., Ltd., an affiliate of HUGEL. The monophasic HA gel formulations contain 0.3% lidocaine and are differentiated by HA concentration and gel elasticity. Dermalax Plus is positioned for fine lines, Deep Plus for more pronounced facial folds, and Implant Plus for firmer volume and contour support. Public product brochures list 1.1 mL prefilled syringes, with the number of syringes per box depending on the variant.
Key Features
- Three distinct gel profiles. Plus, Deep Plus and Implant Plus form a progression from the lowest to the highest elastic modulus reported in a Dermalax brand brochure.
- Cross-linked, monophasic HA. The range consists of cohesive hyaluronic acid gels, with 20 mg/mL HA in Plus and 24 mg/mL in Deep Plus and Implant Plus.
- 0.3% lidocaine formulations. The documented Plus series includes lidocaine at 3 mg/mL; it is a local anesthetic component rather than a measure of filler firmness.
- Variant-specific presentation. Published materials list one 1.1 mL syringe for Plus and Deep Plus, and two 1.1 mL syringes for Implant Plus per box.
- Manufactured by ACROSS, part of the HUGEL network. HUGEL identifies ACROSS as the producer of Dermalax and lists Dermalax among its international HA filler brands.
Composition & Specifications
| Specification | Details |
|---|---|
| Product Family | Dermalax Plus / Dermalax Deep Plus / Dermalax Implant Plus |
| Category | Cross-linked hyaluronic acid injectable dermal filler |
| Legal Manufacturer | ACROSS Co., Ltd., Republic of Korea (identified by HUGEL as the Dermalax producer) |
| Associated Group | HUGEL, Inc. |
| Main Material | Stabilized, cross-linked hyaluronic acid (HA) |
| Gel Structure | Monophasic HA gel, as described in Dermalax product literature |
| HA Concentration | Plus: 20 mg/mL; Deep Plus and Implant Plus: 24 mg/mL |
| Lidocaine Content | 0.3% (3 mg/mL) in the documented Plus formulations |
| Syringe Fill Volume | 1.1 mL per prefilled syringe, according to the later Dermalax product brochure |
| Pack Configuration | Plus: 1 syringe; Deep Plus: 1 syringe; Implant Plus: 2 syringes, as listed in the referenced brochure |
| Brochure-Listed Storage | 2–25°C; protect from direct sunlight and freezing |
| Brochure-Listed Shelf Life | 24 months; verify the actual expiry date and current market-specific label |
Specifications are based on HUGEL corporate information and historical Dermalax-branded product literature, supplemented by distributor listings. An older presentation reports different HA concentrations, syringe volumes and storage limits. The actual product carton and current instructions for use (IFU) must take precedence.
How the Dermalax Gel Formulations Work
Hyaluronic acid is a water-binding component of the extracellular matrix. Cross-linking creates a gel intended to provide temporary physical volume and tissue support. In a monophasic filler, HA forms a cohesive gel structure rather than a suspension of distinct gel particles. The behavior of a finished dermal filler depends on its overall composition and rheological properties, not on HA concentration alone.
A Dermalax brand brochure reports progressively higher storage modulus (G′) values from Plus to Implant Plus. G′ describes the elastic response of a material under the specified test conditions; a higher value generally indicates a greater resistance to deformation in that test. These historical, manufacturer-reported values help explain the three formulation profiles but do not establish comparative clinical effectiveness, safety, treatment duration, or permitted anatomical uses.
Available Variants: Plus, Deep Plus & Implant Plus
The three Dermalax fillers share a cross-linked HA and lidocaine formulation concept but differ in concentration, reported gel elasticity and package size. The profiles below describe the manufacturer's product positioning; individual indications depend on local authorization.
| Variant | HA Concentration | Brochure-Reported G′ | Relative Gel Profile | Product Positioning | Pack |
|---|---|---|---|---|---|
| Dermalax Plus | 20 mg/mL | 80 ± 15 Pa | Softest of the three | Fine lines and relatively superficial facial wrinkle correction | 1 × 1.1 mL syringe |
| Dermalax Deep Plus | 24 mg/mL | 160 ± 15 Pa | Intermediate elasticity | More pronounced facial folds and soft-tissue volume correction | 1 × 1.1 mL syringe |
| Dermalax Implant Plus | 24 mg/mL | 280 ± 15 Pa | Firmest of the three | Deeper folds and facial volume or contour support | 2 × 1.1 mL syringes |
G′ values are reproduced from historical Dermalax-branded literature for within-range reference only; current test conditions and lot-specific results were not independently verified. Supplied needle gauges and quantities vary across distributor descriptions and are deliberately not standardized in this comparison.
Storage & Handling
A published Dermalax product brochure lists storage at 2–25°C, away from direct sunlight and freezing. Earlier presentation materials use a different upper temperature limit. For stock management and transport, follow the exact carton and the most recent manufacturer-approved IFU for the supplied SKU and destination market.
Dermalax HA fillers are sterile, single-use injectable medical devices intended for appropriately qualified healthcare professionals. Review the product-specific indications, contraindications, warning information, expiry date and sterile-package integrity before use. Hyaluronic acid fillers can cause adverse events, including infection, nodules and serious vascular complications. This page does not provide injection methods or treatment recommendations.
Frequently Asked Questions
What is the difference between Dermalax Plus, Deep Plus and Implant Plus?
Dermalax Plus contains 20 mg/mL HA and has the lowest reported gel elasticity of the three. Deep Plus and Implant Plus contain 24 mg/mL HA, with Implant Plus showing the highest reported G′ in the referenced brand brochure. Their marketed correction profiles progress from fine lines toward deeper folds and facial volume support.
Do all three Dermalax Plus fillers contain lidocaine?
The documented Dermalax Plus, Deep Plus and Implant Plus presentations each list lidocaine at 0.3%, equivalent to 3 mg/mL. Confirm the original carton before use because the broader Dermalax brand also includes other presentations.
Who manufactures Dermalax fillers?
ACROSS Co., Ltd. in South Korea manufactures Dermalax. HUGEL identifies Dermalax as an export-market HA filler brand produced by its affiliate ACROSS.
How many syringes are included in each Dermalax box?
The referenced later product brochure lists one 1.1 mL syringe in Dermalax Plus and Deep Plus boxes, and two 1.1 mL syringes in an Implant Plus box. Confirm the packaging of the exact item supplied.
What does G′ mean for a hyaluronic acid filler?
G′ is the storage modulus, a laboratory measure of elastic response. The Dermalax brochure reports approximately 80 ± 15 Pa for Plus, 160 ± 15 Pa for Deep Plus and 280 ± 15 Pa for Implant Plus. These numbers are source-reported and are not a direct clinical-performance comparison.
Are Dermalax fillers approved for use in every country?
No worldwide approval can be assumed. Regulatory status, authorized indications and product labeling must be verified independently for the precise Dermalax variant and destination country. Historical CE-related claims in marketing brochures are not proof of current certification.
Product Information Sources
- HUGEL — ACROSS Identified as the Manufacturer of Dermalax (Corporate News, 2023)
- Dermalax — Branded Product Brochure: Plus, Deep Plus and Implant Plus Specifications (Distributor-Hosted PDF)
- Dermalax & THE CHAEUM — Archived Brand Brochure with Reported HA Concentrations and G′ Values
- U.S. FDA — General Dermal Filler Safety and Regulatory Information